Development
e-therapeutics plc
ETXPF
OTC PK
| 07/31/2023 | 04/30/2023 | 01/31/2023 | 10/31/2022 | 07/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 31.96M | 31.23M | 39.04M | 36.43M | 26.54M |
| Total Receivables | 388.40K | 379.70K | 319.00K | 297.70K | 228.70K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 832.20K | 813.40K | 681.20K | 635.70K | 685.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 3.26M | 3.19M | 1.85M | 1.72M | 2.66M |
| Total Current Assets | 36.44M | 35.62M | 41.88M | 39.09M | 30.11M |
|
|
|||||
| Total Current Assets | 36.44M | 35.62M | 41.88M | 39.09M | 30.11M |
| Net Property, Plant & Equipment | 225.10K | 220.00K | 492.70K | 459.80K | 750.70K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 387.20K | 378.40K | 294.40K | 274.70K | 221.40K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 37.05M | 36.21M | 42.67M | 39.82M | 31.08M |
|
|
|||||
| Total Accounts Payable | 1.53M | 1.49M | 528.40K | 493.20K | 837.10K |
| Total Accrued Expenses | -- | -- | 835.20K | 779.40K | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 115.80K | 113.10K | 363.40K | 339.10K | 492.80K |
| Total Finance Division Other Current Liabilities | -- | -- | 239.00K | 223.00K | -- |
| Total Other Current Liabilities | -- | -- | 239.00K | 223.00K | -- |
| Total Current Liabilities | 1.64M | 1.60M | 1.97M | 1.83M | 1.33M |
|
|
|||||
| Total Current Liabilities | 1.64M | 1.60M | 1.97M | 1.83M | 1.33M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | 108.30K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.64M | 1.60M | 1.97M | 1.83M | 1.44M |
|
|
|||||
| Common Stock & APIC | 145.62M | 142.33M | 139.44M | 130.12M | 121.39M |
| Retained Earnings | -110.21M | -107.72M | -98.73M | -92.14M | -91.74M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 35.41M | 34.61M | 40.70M | 37.99M | 29.65M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 35.41M | 34.61M | 40.70M | 37.99M | 29.65M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 35.41M | 34.61M | 40.70M | 37.99M | 29.65M |
|
|
|||||